Phase 2 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have T cell acute lymphoblastic leukaemia (ALL) or T cell lymphoblastic lymphoma that has not previously been treated, including those whose cancer did not respond to one initial round of chemotherapy, or those whose cancer is in remission after no more than two rounds of chemotherapy.
- People whose overall health and ability to carry out daily activities meets a certain minimum level, as measured by a standard medical scoring system (confirm with trial site).
- People whose liver function blood test results are within acceptable ranges, as determined by the trial team.
- People whose kidney function blood test results are within acceptable ranges, as determined by the trial team.
Who may not be able to join:
- Women who are pregnant or currently breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Farhad Ravandi-Kashani, M.D. Anderson Cancer Center
Phone: 713-745-0394
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complete remission rate; Duration of remission; Progression-free survival; Overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.